Ukinuta odobrenja, povlačenje serija lijekova, pisma zdravstvenim radnicima i novi lijekovi EU — svakodnevno, automatski. Zadnje ažuriranje: 27. 9. 2026. 13:39
Izvori: promjene pratimo na temelju informacija Agencije za lijekove i medicinske proizvode (HALMED) — rješenja o ukidanju odobrenja, obavijesti o povlačenju serija i pisma zdravstvenim radnicima. Odluke o centralizirano odobrenim lijekovima dolaze iz registra Unije Europske komisije (oznaka EU). Nestašice i liste lijekova HZZO-a ovdje (još) nisu uključene.
br. EU/1/26/2050 · Prophylaxis of influenza in adults 50 years of age and older.
Aujemflu should be used in accordance with of… · Seqirus Netherlands B.V. · influenza vaccine (surface antigen, inactivated, adjuvanted, prepared in cell cultures) · ATC J07BB02
br. EU/1/26/2028 · mCOMBRIAX is indicated for active immunisation for the prevention of influenza disease and COVID-19 caused by … · Moderna Biotech Spain S.L. · Influenza and COVID 19, mRNA vaccine · ATC Pending
br. EU/1/26/2016 · Supemtek is indicated for active immunisation for the prevention of influenza disease in adults and children f… · Sanofi Winthrop Industrie · Trivalent influenza vaccine (recombinant, prepared in cell culture) · ATC J07BB02
br. EU/1/18/1326 · odobreno 12. 12. 2018. · Prophylaxis of influenza in adults and children from 6 months of age.
Flucelvax Tetra should be used in ac… · Seqirus Netherlands B.V. · influenza vaccine (surface antigen, inactivated, prepared in cell cultures) · ATC J07BB02
br. EU/1/20/1433 · odobreno 20. 5. 2020. · Prophylaxis of influenza in adults 50 years of age and older.
Fluad Tetra should be used in accordance with… · Seqirus Netherlands B.V. · influenza vaccine (surface antigen, inactivated, adjuvanted) · ATC J07BB02
br. EU/1/13/887 · odobreno 4. 12. 2013. · Prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age.
The use o… · AstraZeneca AB · influenza vaccine (live attenuated, nasal) · ATC J07BB03
Lekoskop